ABSTRACT A method using lucigenin-dependent phagocytic chemiluminescence is described for the assessment of alveolar macrophage metabolic activity in response to stimulation by opsonised particles or soluble agents. The requirement for superoxide anion (02-) 
The alveolar macrophage (AM) is the resident phagocytic cell in the lower respiratory tract and a role for its involvement in the aetiology of various diseases has been demonstrated.1 Stimulation of the cell membrane either by adherence of opsonised particles or by soluble agents such as the co-carcinogen phorbol myristate acetate leads to the increased production of hydrogen peroxide and superoxide anion (02-).2Inaddition to being important microbicidal agents, these reactive substances and their products have been implicated in the pathogenesis of respiratory membrane damage in paraquat poisoning3 and after exposure to high concentrations of oxygen. 4 Bronchoalveolar lavage during fibreoptic bronchoscopy harvests human alveolar macrophages but methods investigating phagocytic metabolic activity often require more cells than are obtained by this technique. Luminol-dependent chemiluminescence, which requires comparatively few cells, has been used as an assay of phagocytic oxidative metabolism in polymorphonuclear leucocytes and for investigation of the opsonic activity of serum. Phorbol myristate acetate (Sigma) was dissolved in dimethylsulfoxide (I mg/ml) and then diluted in phosphate buffered saline (1:2000) . Lucigenin (10-4M; Sigma) was dissolved in Hanks's balanced salt solution buffered with 20 mM HEPES (N-2-hydroxyethylpiperazine-N-2-ethanesulphonic acid).
Chemiluminescence was measured at 370 using a photometer (Luminometer 1250; LKB Wallac). The alveolar macrophage suspension (500 ,ul) was added to lucigenin (900 vl) with 0-1 % gelatin in a reaction vial which was placed in the carousel of the photometer. Opsonised zymosan suspension (100 ,l) or phorbol myristate acetate (100 ,ul) was added to the mixture and the light produced was monitored graphically on a chart recorder (LKB-Bromma 2210). The reading 12 minutes after addition of particles or soluble stimulant was used for analysis.
Superoxide anion release was estimated by superoxide dismutase inhibitable ferricytochrome C reduction.'2 Opsonised zymosan (100 ,tl) or phorbol myristate acetate (100 ,ul) was added to 1-5 ml AM suspension (106 cells/ml with 0-1 % gelatin) in the presence of 26 mM oxidised ferricytochrome C (horse heart type VI; Sigma). The vials were incubated at 37°for 15 minutes in parallel with vials that in addition contained superoxide dismutase (60 ,tg/ml; Sigma). After incubation the suspension was centrifuged (4000 g for 10 minutes) and, using the supernatant, 02-release was estimated spectrophotometrically at 550 nm (extinction coefficient = 21'1 mM-1 cm-').
Results and discussion . This is in contrast to the situation with luminoldependent chemiluminescence.9 There is no correlation (r = 0003; n = 28) with lymphocyte contamination and this observation is supported by the absence of response when using a purified lymphocyte preparation from peripheral blood. Lucigenin-dependent phagocytic chemiluminescence is more than 95 % suppressed by superoxide dismutase (30 ,ug/ml) implicating the involvement of 02-in its production. Figure 2 shows the correlation (correlation coefficient = 0O61, p < 005) between chemiluminescence and 02-production as measured by ferricytochrome C reduction (n = 11). This technique differs in that measurements are made upon the supernatant after a period of incubation followed by centrifugation-that is, after production of the 02-because particles and cells interfere with the spectrophotometric assay. In contrast, the chemiluminescence assay can be used to monitor 02-production as it occurs. This can be of benefit when assessing the interaction between membrane receptor sites on the phagocytic cell and opsonins coating the 
